Skip to content

The comparison of Clonidine and magnesium sulfate on depth of anesthesia during cesarean section under general anesthesia

The comparison of Clonidine and magnesium sulfate on depth of anesthesia during cesarean section under general anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013021112425N1
Enrollment
120
Registered
2014-03-12
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depth of anesthesia. Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Interventions

Intervention 1: Group 1:tab clonidine 0/2 mg ,1hour befor induction and infusion of 100 cc normal saline(placebo) ,during 10 minutes befor induction of anesthesia. Intervention 2: Group 2:Sulfate Magn
Treatment - Drugs
Group 1:tab clonidine 0/2 mg ,1hour befor induction and infusion of 100 cc normal saline(placebo) ,during 10 minutes befor induction of anesthesia
Group 2:Sulfate Magnesiom 30 mg/kg that is solued in 100 cc normal saline will be given during 10 minutes
Group 3:control group,that will be given 100 cc normal saline(placebo) during 10 minutes befor induction of anesthesia

Sponsors

Vice Chancellor of Research, Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion critria : pregnant women; ASA-1; elective cesarean section exclusion critria: hypertention; diabet; renal disease; cardiovascular disease; preeclampsy; allergy of clonidine or magnesiom sulfate; using of antiepileptic drug; difficult intubation; depression or other psycological disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depth of anesthesia. Timepoint: After induction,after intubation,after delivery. Method of measurement: With cerebral state monitoring device.

Secondary

MeasureTime frame
Awareness. Timepoint: The day after surgery. Method of measurement: Question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hamidi Shad

kashan University of Medical Sciences

maryamhamidishad@yahoo.com+98 36 1555 0026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026